DarioHealth Prices $23.5 Million Stock Offering at Market Value
DarioHealth Corp. announced in a press release that it has priced a registered direct offering of approximately $23.5 million in common stock at $6.80 per share. The offering involves the sale of 3,454,559 shares to existing institutional investors and new participants.
A member of DarioHealth's board of directors also took part, purchasing 14,430 shares at $6.93 per share. A.G.P./Alliance Global Partners is acting as the sole placement agent for the transaction.
Gross proceeds from the offering are expected to be about $23.5 million before fees and expenses. The closing is anticipated on or about July 23, 2026, subject to standard closing conditions. DarioHealth plans to use the funds for working capital, investments, acquisitions, and general corporate purposes.
The securities are being issued under an effective shelf registration statement on Form S-3 (File No. 333-294454) that became effective on March 27, 2026. A prospectus supplement will be filed with the U.S. Securities and Exchange Commission and made available through its website.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Sep 22 AI Hospitality Group Launches Hotel Operator With $7.5 Million Sep 22 Adlib Software Agrees to Acquire Paperbox Sep 22 Searchable Acquires AI Search Startup Meridian Sep 22 Hunt Scanlon Ventures Invests in Millionways Sep 22 Feldera Raises $21.5 Million to Cut Database Compute CostsMore from Life Sciences
Sep 22 CIPRA.ai and Murata Explore AI Wearables for Chronic Care Sep 22 CentralReach Releases ReportDraftAI for ABA Reporting Sep 20 IDC Names ZS a Leader in Life Sciences Evidence Services Sep 20 Brainomix Selected for UK Future Fifty Programme Sep 19 Rutgers and RWJBarnabas Health Launch AWS Health Innovation HubLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Onos Health Raises $17 Million for Behavioral Health AI Platform
Arintra Raises $25 Million for Healthcare Revenue Assurance AI
Kairon Health Raises $5 Million for AI Care Operations Platform
Healthcare Triangle Joins Kanzun-ARCB Fund to Connect Malaysian Companies With US Capital
Metriport Raises $26 Million for Patient Record Platform
Daily AI Brief: the AI news that matters, in your inbox.